11
Participants
Start Date
November 17, 2020
Primary Completion Date
March 30, 2022
Study Completion Date
March 30, 2022
PF-06946860
subcutaneous injection
American Oncology Partners of Maryland, PA, Bethesda
American Oncology Partners of Maryland, PA, Germantown
Duke Cancer Center, Durham
Tallahassee Memorial Healthcare Cancer Center, Tallahassee
Fort Wayne Medical Oncology and Hematology, Inc., Fort Wayne
Lutheran Medical Center, Wheat Ridge
SCL Health Cancer Centers of Colorado - St. Mary's Hospital and Regional Medical Center, Grand Junction
Beverly Hills Cancer Center, Beverly Hills
VA Puget Sound Health Care System, Seattle
New England Cancer Specialists, Scarborough
Lead Sponsor
Pfizer
INDUSTRY